Omada Health director granted 10,882 RSUs

Jain Sachin H. reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 06/18/2026 - 04:19 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Jain Sachin H. reported acquisition or exercise transactions in this Form 4 filing.

Omada Health, Inc. director Sachin H. Jain received a grant of 10,882 restricted stock units, each convertible into one share of Common Stock upon vesting. After this award, he holds 20,618 shares of Common Stock directly. The RSUs vest 100% on the earlier of the first anniversary of the grant date or the date of Omada Health’s 2027 Annual Meeting of stockholders, contingent on his continued service through that vesting date.

Insider Trade Summary

Grant/Award: 10,882 shares

Grant/Award 1 txn

Insider Jain Sachin H.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	10,882	$0.00	$0.00

Holdings After Transaction: Common Stock — 20,618 shares (Direct)

Holdings Before and After: Common Stock, 9,736 to 20,618 shares (Direct)

Footnotes (1)

1. F1. Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will fully vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2027 Annual Meeting of the Issuer's stockholders, subject to continued service through such vesting date.

Key Figures

RSUs granted: 10,882 units Shares after transaction: 20,618 shares Price per share: $0.0000 per share +1 more

4 metrics

RSUs granted 10,882 units Equity award to director Sachin H. Jain

Shares after transaction 20,618 shares Total Common Stock held directly after grant

Price per share $0.0000 per share Reported transaction price for RSU grant

Vesting trigger Earlier of 1-year anniversary or 2027 meeting 100% RSU vesting condition, subject to continued service

Key Terms

restricted stock units ("RSUs"), vesting, Annual Meeting of the Issuer's stockholders, Common Stock

4 terms

restricted stock units ("RSUs") financial

"Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

vesting financial

"one (1) share of Common Stock for each RSU upon vesting"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Annual Meeting of the Issuer's stockholders regulatory

"the date of the 2027 Annual Meeting of the Issuer's stockholders"

Common Stock financial

"one (1) share of Common Stock for each RSU upon vesting"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Omada Health (OMDA) report for Sachin H. Jain?

Omada Health reported that director Sachin H. Jain received a grant of 10,882 restricted stock units. Each RSU represents the right to receive one share of Common Stock when the units vest, increasing his direct holdings to 20,618 shares.

How many Omada Health shares does Sachin H. Jain hold after this Form 4 filing?

Following the reported grant, Sachin H. Jain beneficially owns 20,618 shares of Omada Health Common Stock directly. This total includes the newly granted 10,882 restricted stock units, which will convert into shares once they vest under the stated conditions.

When do Sachin H. Jain’s Omada Health RSUs from this grant fully vest?

All 10,882 RSUs will fully vest on the earlier of the first anniversary of the grant date or the date of Omada Health’s 2027 Annual Meeting of stockholders. Vesting is subject to Jain’s continued service through that vesting date.

What type of equity award did Omada Health (OMDA) grant to Sachin H. Jain?

Omada Health granted Sachin H. Jain restricted stock units, or RSUs, which are a form of equity compensation. Each RSU entitles him to receive one share of Common Stock upon vesting, rather than requiring any cash payment per share.

Does Sachin H. Jain pay a price per share for these Omada Health RSUs?

The Form 4 shows a transaction price per share of $0.0000 for the 10,882-share grant. This reflects that RSUs are typically awarded as compensation and convert into Common Stock upon vesting, rather than being purchased in a cash transaction.

What service condition applies to Sachin H. Jain’s Omada Health RSU grant?

The RSUs vest only if Sachin H. Jain continues his service through the vesting date. Full vesting occurs on the earlier of the first anniversary of the grant date or the 2027 Annual Meeting of stockholders, making ongoing service a key requirement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jain Sachin H.

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD., SUITE 120

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/16/2026		A		10,882(1)	A	$0	20,618	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will fully vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2027 Annual Meeting of the Issuer's stockholders, subject to continued service through such vesting date.

	/s/ Nathan Salha, as Attorney-in-Fact for Sachin H. Jain	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)